Drug Profile
Naxagolide
Alternative Names: L 647339Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Antiparkinsonians; Neuroprotectants; Oxazines; Small molecules
- Mechanism of Action Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 24 Jan 1995 Discontinued-I for Parkinson's disease in Japan (PO)
- 24 Jan 1995 Discontinued-II for Parkinson's disease in USA (PO)